Related Experiment Video

Updated: May 1, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K

Unravelling the multifaceted roles of Atg proteins to improve cancer therapy

Y Chen1, X-R Liu, Y-Q Yin

  • 1Department of Gastrointestinal Surgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.

Cell Proliferation
|March 26, 2014
PubMed

Insights

Autophagy, a cellular degradation process regulated by autophagy-related genes (Atgs), plays a complex role in cancer. Understanding Atgs and their miRNA regulation is key for developing novel cancer therapies.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Gene Regulation

Background:

  • Autophagy is a fundamental cellular process for degrading damaged components via a lysosomal pathway.
  • Autophagy is tightly regulated by autophagy-related genes (Atgs) and their protein products, essential for autophagosome formation.
  • The precise role of autophagy in cancer development and progression remains incompletely understood.

Purpose of the Study:

  • To review the critical involvement of Atgs in cancer cell fate.
  • To discuss specific Atgs (e.g., ULK, Beclin-1, Atg8/LC3-Atg4) and their regulatory mechanisms, including microRNA (miRNA) involvement.
  • To highlight Atgs as potential therapeutic targets for cancer treatment.

Main Methods:

  • Literature review of existing studies on autophagy, Atgs, and cancer.
  • Analysis of the regulatory roles of Atgs in oncogenic and tumor-suppressive pathways.
  • Examination of miRNA-mediated regulation of key Atgs.

Main Results:

  • Autophagy-related genes (Atgs) significantly influence carcinogenesis by modulating key cellular pathways.
  • Specific Atgs, such as ULK, Beclin-1, and the Atg8/LC3-Atg4 system, are implicated in cancer progression.
  • MicroRNAs (miRNAs) are identified as regulators of these crucial Atgs, adding another layer of complexity.

Conclusions:

  • Autophagy-related genes (Atgs) are pivotal in determining cancer cell survival and proliferation.
  • Targeting Atgs, potentially modulated by miRNAs, offers a promising strategy for innovative cancer therapies.
  • Further research into Atg-miRNA interactions could unlock new avenues for effective cancer treatment.

More Related Videos

Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein07:20

Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein

Published on: June 16, 2023

4.5K
siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells09:10

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

9.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K